Stay updated on Pembrolizumab in 1st Line NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in 1st Line NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in 1st Line NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; removed the 'Back to Top' element.
    Difference
    0.1%
    Check dated 2025-09-13T16:55:14.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-06T14:20:48.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information for various compounds, including Pembrolizumab and Cisplatin, and has added specific facility locations in Japan. Additionally, the revision number has been updated to v3.0.0.
    Difference
    8%
    Check dated 2025-08-30T11:09:13.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:30:28.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.2%
    Check dated 2025-08-08T23:48:39.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.8%
    Check dated 2025-08-01T19:14:40.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in 1st Line NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in 1st Line NSCLC Clinical Trial page.